IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
ertapenem
ertapenem
Restricted Medications
Non-Formulary
Brand names:
INVanz
Form
Strength
POWDER FOR INJECTION, INJECTABLE
1 g
Display
Carbapenems
Class:
08120708
Medication comments:
β-Lactam Use/Allergies Policy
IV Push Guidelines
Per policy, these drugs are subject to renal dosing adjustments by pharmacy.
View all
Renal Dosing Program
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
ertapenem
IV/IM
(
INVanz
©
)
1 gm q24h
CrCl > 30: No adjustment necessary
CrCl ≤ 30: 500 mg q24h
HD: 500 mg q24h
Per policy, orders for these non-formulary agents will be changed to formulary equivalents.
View all
Non-Formulary Agent
Formulary Equivalent
ertapenem (INVanz)
meropenem (Merrem) dosed according to protocol
Last updated:
May. 25, 2021
Renal Adjustment Policy
ertapenem subject to adjustments by pharmacy.
Therapeutic Interchange Policy
meropenem (Merrem)
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
• Indications
Comments
(INVanz©)
CrCl ≤ 30: 500 mg q24h
HD: 500 mg q24h